Kolderma Instituto De Pesquisa Clinica Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01011621
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

KOLderma

Active Ingredients

Drugs in Phase 3 Trials (2)

betamethasone (celestone) (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Dermatitis, Contact (Phase 3)

Dermatitis, Seborrheic (Phase 3)

Psoriasis (Phase 3)

Skin Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2